Primary Hyperoxaluria Clinical Trials in Rochester, Minnesota
4 recruitingRochester, Minnesota
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Primary Hyperoxaluria Type 1 (PH1)
Arbor Biotechnologies23 enrolled7 locationsNCT06839235
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420
Recruiting
Rare Kidney Stone Consortium Biobank
CystinuriaDent DiseasePrimary Hyperoxaluria+1 more
Mayo Clinic2,000 enrolled1 locationNCT02026388
Recruiting
Rare Kidney Stone Consortium Patient Registry
CystinuriaDent DiseasePrimary Hyperoxaluria+1 more
Mayo Clinic730 enrolled4 locationsNCT00588562